Table 1.
Basic characteristics for patients (a) without DM and (b) with DM
| Whole | HbA1c (%) | P value | ||
|---|---|---|---|---|
| ≤5.7 | >5.7 | |||
| (a) | ||||
| Patient number | 272 | 142 | 130 | |
| Average HbA1c (%) | 5.73 ± 0.76 | 5.46 ± 0.21 | 6.05 ± 0.18 | <0.001 |
| Age (years) | 59.84 ± 10.71 | 59.79 ± 10.44 | 59.90 ± 11.03 | 0.93 |
| Female (%) | 20.96% | 20.28% | 26.15% | |
| BMI (kg/m2) | 24.81 ± 3.15 | 24.96 ± 3.25 | 24.54 ± 3.02 | 0.4 |
| Current/exsmoker (%) | 57.72% | 60.84% | 56.77% | |
| Systolic BP (mmHg) | 124.25 ± 20.07 | 124.49 ± 19.19 | 123.78 ± 17.83 | 0.75 |
| DiastolicBP (mmHg) | 77.44 ± 12.56 | 77.36 ± 11.26 | 77.45 ± 10.87 | 0.95 |
| FBG (mg/dL) | 6.05 ± 2.07 | 5.82 ± 1.61 | 6.15 ± 2.24 | 0.23 |
| Ejection fraction (%) | 59.25 ± 19.47 | 59.21 ± 13.01 | 59.12 ± 12.19 | 0.95 |
| LDL-C (mmol/L) | 2.28 ± 0.83 | 2.36 ± 0.72 | 2.19 ± 0.79 | 0.07 |
| Creatine (µmol/L) | 68.54 ± 15.72 | 68.75 ± 16.11 | 68.17 ± 15.19 | 0.76 |
| Previous history of hypertension (%) | 49.63% | 51.05% | 55.20% | |
| CHF (%) | 6.99% | 7.69% | 6.27% | |
| Myocardial infarction (%) | 16.18% | 22.38% | 24.74% | |
| PCI or CABG (%) | 19.49% | 18.88% | 16.64% | |
| In hospital treatment aspirin (%) | 95.96% | 96.50% | 95.67% | |
| β-Blocker (%) | 82.72% | 80.42% | 78.66% | |
| Statin (%) | 93.75% | 97.20% | 97.23% | |
| CCB (%) | 30.88% | 20.28% | 15.44% | |
| Whole | HbA1c (%) | P value | ||
|---|---|---|---|---|
| ≤7.1 | >7.1 | |||
| (b) | ||||
| Patient number | 137 | 60 | 77 | |
| Average HbA1c (%) | 7.86 ± 1.56 | 6.53 ± 0.36 | 6.53 ± 0.36 | <0.001 |
| Age (years) | 61.00 ± 10.41 | 57.52 ± 10.15 | 64.05 ± 10.17 | 0.003 |
| DM duration (years) | 4.33 ± 5.91 | 2.83 ± 4.52 | 5.71 ± 6.67 | <0.001 |
| Female (%) | 20.44% | 16.70% | 25.12% | |
| BMI (kg/m2) | 25.80 ± 2.76 | 25.84 ± 2.57 | 25.78 ± 2.92 | 0.95 |
| Current/exsmoker (%) | 56.20% | 73.29% | 49.73% | |
| Systolic BP (mmHg) | 127.99 ± 20.45 | 126.18 ± 22.40 | 129.40 ± 18.82 | 0.36 |
| DiastolicBP (mmHg) | 79.47 ± 11.80 | 79.61 ± 12.76 | 79.36 ± 11.07 | 0.9 |
| Fasting plasma glucose | 7.39 ± 2.95 | 7.22 ± 3.08 | 7.54 ± 2.82 | 0.47 |
| Ejection fraction (%) | 56.61 ± 18.07 | 56.73 ± 11.70 | 56.51 ± 11.84 | 0.92 |
| LDL-C (mmol/L) | 2.20 ± 0.93 | 2.35 ± 0.95 | 2.08 ± 0.84 | 0.08 |
| Creatine (µmol/L) | 71.68 ± 28.41 | 69.88 ± 21.91 | 73.08 ± 32.66 | 0.52 |
| Previous history of hypertension (%) | 59.85% | 54.97% | 55.83% | |
| CHF (%) | 8.03% | 6.69% | 8.36% | |
| Myocardial infarction (%) | 19.71% | 20.02% | 26.52% | |
| PCI or CABG (%) | 24.82% | 26.73% | 35.80% | |
| In hospital treatment aspirin (%) | 98.54% | 40.28% | 97.68% | |
| β-Blocker (%) | 89.05% | 96.64% | 89.76% | |
| Statin (%) | 99.27% | 100.00% | 100.00% | |
| CCB (%) | 27.74% | 21.68% | 27.92% | |
| Insulin (%) | 17.78% | 13.64% | 21.74% | |
| Metformin (%) | 0.00% | 0.00% | 0.00% | |
| Acarbose (%) | 35.56% | 27.27% | 43.48% | |
| Sulfonylureas (%) | 13.33% | 9.09% | 17.39% | |
Data are mean ± SD and number (%)
DM diabetes mellitus, HbA 1c, hemoglobin A1c, BMI body mass index, BP blood pressure, FBG fasting blood glucose, CHF chronic heart failure, PCI percutaneous coronary intervention, CABG coronary artery bypass graft, LDL-C low density lipoprotein-cholesterol, CCB calcium channel blocker